Search Results 261-270 of 7179 for paradisegoa
Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Brentuximab vedotin may interfere with the ability of ...
About this study. The purpose of this study is to explore various biomarkers in the post-treatment tissue of patients who have responded to cancer therapy ...
About this study. The primary purpose of this study is to analyze maxillary transverse dimensions in children who have completed polysomnography (PSG), ...
The purpose of this study is to assess the effectiveness of an intervention program promoting emotional and cognitive health to modify high levels of perceived ...
Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer (ovarian cancer). Participation eligibility.
Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...
About this study. The primary objective of this study is to employ the social determinant of migrant health framework (International Organization for ...
This is a randomized, open label, multicenter phase III trial to determine the efficacy and safety of tisagenlecleucel treatment strategy in adult patients with ...
About this study. The objective of this proposal is to evaluate MRI hardware and software features that have potential to improve the interventional MRI ...
About this study. This randomized phase III trial studies how well combination chemotherapy (vincristine sulfate, dactinomycin, cyclophosphamide alternated ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.